#Tendyne
LightNews LightNews
davidmogeladze.bsky.social
bioengineer.org/repositionab...
Repositionable Tendyne valve shows promise for high-risk patients with
A European registry of 16 high-risk patients reports 100 percent technical success, no outflow tract obstruction, and durable symptom improvement after repositionable Tendyne transcatheter valves were
bioengineer.org
November 6, 2026 at 1:20 AM
cvrcbern.bsky.social
New publication: Interdisciplinary periprocedural management of patients undergoing transapical tmvi with the tendyne™ system: A narrative review and institutional experience. Congratulations to the authors! pubmed.ncbi.nlm.nih.gov/40811142/
#CVRCBern
Interdisciplinary periprocedural management of patients undergoing transapical tmvi with the tendyne™ system: A narrative review and institutional experience - PubMed
TMVI with the Tendyne™ valve provides a viable and effective treatment for selected patients with symptomatic moderate to severe MR. Optimal outcomes are dependent on meticulous interdisciplinary coll...
pubmed.ncbi.nlm.nih.gov
October 21, 2025 at 9:14 AM
eurointervention.bsky.social
A successful double transcatheter valve replacement (mitral + tricuspid) using Tendyne and LuX-Valve in a high-risk patient.
When TEER is not an option, replacement may be the key.
#Tendyne #LuXValve #StructuralHeart #TVR #cardiosky
ow.ly/GgP150VeuO4
March 10, 2025 at 4:40 PM
longtail-news.bsky.social
Feed: "Medical Device Network"
By: gullapalli on Wednesday, May 28, 2025
FDA approves Abbott’s TMVR system to treat mitral valve disease
The US Food and Drug Administration (FDA) has granted approval for Abbott's Tendyne transcatheter mitral valve replacement (TMVR) system.
www.medicaldevice-network.com
May 28, 2025 at 3:51 PM
victorchang.edu.au
#PaulKornerSeminar speaker Sara Hungerford: "Always look on the right side of life" - right ventricular remodelling following #Tendyne mitral valve replacement. #heartresearch #WomenInScience
December 5, 2024 at 1:54 AM
victorchang.edu.au
#PaulKornerSeminar speaker Sara Hungerford: "Always look on the right side of life" - right ventricular remodelling following #Tendyne mitral valve replacement. #heartresearch #WomenInScience
December 5, 2024 at 12:30 AM
citoday.bsky.social
Abbott’s Tendyne TMVR System Approved by FDA
citoday.com/news/abbotts...
Abbott’s Tendyne TMVR System Approved by FDA - Cardiac Interventions Today
May 27, 2025—Abbott announced FDA approval of the company’s Tendyne transcatheter mitral valve replacement (TMVR) system for the treatment
citoday.com
May 27, 2025 at 3:23 PM
accintouch.bsky.social
Findings from SUMMIT-MAC show that #TMVR using the Tendyne system significantly improved #heartfailure symptoms and QoL in patients with severe mitral annular calcification. Read the highlights: https://bit.ly/4qCxF3t

#TCT2025 #JACC #CardioSky #MedSky @jaccjournals.bsky.social
October 27, 2025 at 8:59 PM
patesalo-e.bsky.social
Minimally Invasive Surgical Devices Patent Landscape Report 2025, with Intuitive Surgical, LSI Solutions, Tendyne Holdings, Ethicon Endo Surgery and Invuity – Ortho Spine News - Ortho Spine News: Minimally Invasive Surgical Devices Patent Landscape Report 2025, with Intuitive Surgical, LSI…
Minimally Invasive Surgical Devices Patent Landscape Report 2025, with Intuitive Surgical, LSI Solutions, Tendyne Holdings, Ethicon Endo Surgery and Invuity – Ortho Spine News - Ortho Spine News
Minimally Invasive Surgical Devices Patent Landscape Report 2025, with Intuitive Surgical, LSI Solutions, Tendyne Holdings, Ethicon Endo Surgery and Invuity – Ortho Spine News  Ortho Spine News
news.google.com
April 14, 2025 at 6:16 PM
blueresearch.bsky.social
Abbott announces FDA approval of Tendyne TMVR system
Reported Tuesday, May 27 - 9:02am EDT (TheFly subscription required to read more.)
thefly.com
May 27, 2025 at 1:12 PM
newsen.bsky.social
Abbott's Revolutionary Tendyne Device Gains FDA Approval for Minimally Invasive Mitral Valve Replacement#United_States#Abbott#Abbott_Park#Mitral_Valve#Tendyne
Abbott's Revolutionary Tendyne Device Gains FDA Approval for Minimally Invasive Mitral Valve Replacement
The FDA has approved Abbott's Tendyne device, a groundbreaking solution for mitral valve replacement that avoids the need for open-heart surgery.
third-news.com
May 27, 2025 at 1:29 PM
shoaib9702.bsky.social
6.SUMMIT
(1 year outcome of Tendyne TMVR for severe MAC)
7.ENCIRCLE
(1 year outcome of Sapiens TMVR for pts unsuitable for surgery)
8.PROCTOR.
Native vessel vs SVG PCI in pts with CABG
9.STRIVE:
Low-Dose r-tPA vs. Placebo in STEMI With Large thrombus burdon
August 28, 2025 at 3:20 PM
medpagetoday.com
For selected patients with mitral regurgitation (MR), the Sapien M3 device delivered highly promising 1-year outcomes for the desperate field of transcatheter mitral valve replacement (TMVR).
www.medpagetoday.com/meetingcover...
Sapien M3 TMVR Easily Beats Expectations in Pivotal Trial
Tendyne device also shows promise for desperate MR patients
www.medpagetoday.com
October 29, 2025 at 8:51 PM
l2plabs.bsky.social
Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery
The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers a new treatment option for patients who are not candidates for open-heart surgery or mitral...
dlvr.it
May 27, 2025 at 1:01 PM
tctmd.bsky.social
TMVR with the Tendyne system successfully treats MR or stenosis complicated by severe MAC, improving heart failure symptoms and quality of life, according to findings from the SUMMIT-MAC study presented at #TCT2025. More here: www.tctmd.com/news/tendyne...
Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC
The device, which is delivered transapically, represents an option for very sick patients who previously have had none.
www.tctmd.com
November 8, 2025 at 2:26 PM
tctmd.bsky.social
Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC
Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC
Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC cmacahilig@crf.org Mon, 10/27/2025 - 18:28 Yael L. Maxwell The device, which is delivered transapically, represents an option for very sick patients who previously have had none.
www.tctmd.com
October 27, 2025 at 10:39 PM
tctmd.bsky.social
Tendyne Approved in US for High-risk Patients With Mitral Valve Disease
Tendyne Approved in US for High-risk Patients With Mitral Valve Disease
Tendyne Approved in US for High-risk Patients With Mitral Valve Disease cmacahilig@crf.org Wed, 05/28/2025 - 15:01 Michael O'Riordan The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER.
www.tctmd.com
May 28, 2025 at 7:19 PM
jaccjournals.bsky.social
In this first report of the primary outcomes of the SUMMIT-MAC clinical trial, #TMVR with Tendyne led to successful treatment of mitral valve disease due to MAC and significant improvements in #heartfailure symptoms and #QoL. https://bit.ly/4ovW0pz

#TCT2025 #JACC #SUMMIT #CardioSky
October 27, 2025 at 6:50 PM